Search results
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual...
Nature· 3 days agoThe original sentence “Here we show that a combination of nivolumab plus capecitabine leads to a greater increase in PIS from baseline to week 6 (91%) compared with
Vilcek Foundation Appoints Dr. Jedd Wolchok to Board of Directors
Digital Journal· 3 days agoWolchok's research at Memorial Sloan Cancer Center was instrumental in the clinical development leading to the approval of ipilimumab and the combination of nivolumab and ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript May 7, 2024 Halozyme...
Managing Thyroid Adverse Events From Checkpoint Inhibitors
Medscape· 6 days agoThis podcast was created in partnership with the American Thyroid Association to discuss up-to-date...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 7 days agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Enovis (NYSE:ENOV),...
Benzinga· 6 days agoBristol-Myers Squibb Company BMY On May 6, the U.S. Food and Drug Administration accepted the...
SHP report claims hospitals overcharging for oncology drugs
Winston-Salem Journal· 4 days agoThe latest commissioned report by state Treasurer Dale Folwell — released Wednesday — determined...
Q1 2024 Corvus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoWe'll study completion in early 2025 outside of our PTCO. and atopic dermatitis trials. We are still planning a so-called witness solid tumor trial as a single agent and in combination with ...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 7 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors and contains the active ingredient sorafenib ...
CG Oncology (NASDAQ:CGON) Earns Buy Rating from HC Wainwright
ETF DAILY NEWS· 7 days agoCG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report released on Monday, Benzinga reports. They presently have a $75.00 ...
